EA200501233A1 - 4-аминопиримидин-5-он - Google Patents

4-аминопиримидин-5-он

Info

Publication number
EA200501233A1
EA200501233A1 EA200501233A EA200501233A EA200501233A1 EA 200501233 A1 EA200501233 A1 EA 200501233A1 EA 200501233 A EA200501233 A EA 200501233A EA 200501233 A EA200501233 A EA 200501233A EA 200501233 A1 EA200501233 A1 EA 200501233A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
treating
preparation
useful
cyclin
Prior art date
Application number
EA200501233A
Other languages
English (en)
Other versions
EA009412B1 (ru
Inventor
Дейвид Джозеф Барковиц
Синьцзи Чу
Цинцзи Дин
Нань Цан
Аллен Джон Лови
Джон Антони Молитерни
Джон Гилфойл Джр. Маллин
Бин Тан Ву
Питер Майкл Вовкулич
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Publication of EA200501233A1 publication Critical patent/EA200501233A1/ru
Publication of EA009412B1 publication Critical patent/EA009412B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Описаны новые производные 4-аминопиримидин-5-она формулыгде Rи Rявляются такими, как определено в описании. Эти соединения ингибируют циклинзависимые киназы, в частности циклинзависимую киназу 4 (Cdk4). Эти соединения и их фармацевтически приемлемые соли и эфиры обладают антипролиферативной активностью и являются полезными для лечения или контроля рака, в частности, твердых опухолей. Данное изобретение также относится к фармацевтическим композициям, содержащим такие соединения, их применению для лечения или контроля рака, к способу их получения и к промежуточным соединениям, полезным для их получения.
EA200501233A 2003-02-10 2004-02-03 Производные 4-аминопиримидин-5-она, способ их получения и применение EA009412B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44627303P 2003-02-10 2003-02-10
US51492603P 2003-10-28 2003-10-28
PCT/EP2004/000971 WO2004069139A2 (en) 2003-02-10 2004-02-03 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity

Publications (2)

Publication Number Publication Date
EA200501233A1 true EA200501233A1 (ru) 2006-04-28
EA009412B1 EA009412B1 (ru) 2007-12-28

Family

ID=32853425

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501233A EA009412B1 (ru) 2003-02-10 2004-02-03 Производные 4-аминопиримидин-5-она, способ их получения и применение

Country Status (22)

Country Link
US (2) US7157455B2 (ru)
EP (1) EP1628619A2 (ru)
JP (1) JP2006523183A (ru)
KR (1) KR100717099B1 (ru)
AR (1) AR043693A1 (ru)
AU (1) AU2004210408A1 (ru)
BR (1) BRPI0407381A (ru)
CA (1) CA2512915A1 (ru)
CL (1) CL2004000226A1 (ru)
EA (1) EA009412B1 (ru)
EC (1) ECSP055958A (ru)
HR (1) HRP20050689A2 (ru)
IL (1) IL169626A0 (ru)
MA (1) MA27716A1 (ru)
MX (1) MXPA05008333A (ru)
MY (1) MY137555A (ru)
NO (1) NO20053410L (ru)
PL (1) PL382309A1 (ru)
RS (1) RS20050610A (ru)
TN (1) TNSN05188A1 (ru)
TW (1) TWI293881B (ru)
WO (1) WO2004069139A2 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211576B2 (en) * 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
US7405220B2 (en) 2004-06-09 2008-07-29 Hoffmann-La Roche Inc. Pyrazolopyrimidines
ATE405828T1 (de) * 2005-05-25 2008-09-15 Hoffmann La Roche Biomarker zur reaktionsüberwachung von cdk- hemmern in der klinik
US7705009B2 (en) * 2005-11-22 2010-04-27 Hoffman-La Roche Inc. 4-aminopyrimidine-5-thione derivatives
AU2006319248B2 (en) 2005-12-01 2012-09-27 F.Hoffman-La Roche Ag 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents
WO2007113005A2 (en) * 2006-04-03 2007-10-11 European Molecular Biology Laboratory (Embl) 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors
EP2330908A4 (en) 2008-08-15 2011-11-23 Univ Georgetown FLUORESCENT CDK INHIBITORS FOR CANCER TREATMENT
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP3901159A1 (en) * 2014-07-01 2021-10-27 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
JP2022535852A (ja) * 2019-06-06 2022-08-10 ベイジン タイド ファーマシューティカル カンパニー リミテッド Ｐ２ｘ３及び／又はｐ２ｘ２／３受容体アンタゴニスト、それを含む医薬組成物及びその使用
TW202231633A (zh) * 2021-02-05 2022-08-16 大陸商上海齊魯製藥研究中心有限公司 Cdk抑制劑
WO2024063670A1 (ru) * 2022-09-22 2024-03-28 Акционерное общество "БИОКАД" Ингибиторы циклинзависимой киназы 7

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
JP2001509805A (ja) * 1997-02-05 2001-07-24 ワーナー−ランバート・コンパニー 細胞増殖阻害剤としてのピリド〔２，３−ｄ〕ピリミジンおよび４−アミノピリミジン
NZ503788A (en) 1997-10-27 2002-11-26 Agouron Pharma 4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases
US6262096B1 (en) 1997-11-12 2001-07-17 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
ATE245641T1 (de) 1998-02-17 2003-08-15 Tularik Inc Antivirale pyrimidinderivate
ES2274634T3 (es) 1998-08-29 2007-05-16 Astrazeneca Ab Compuestos de pirimidina.
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
AU777468B2 (en) 1999-09-15 2004-10-21 Warner-Lambert Company Pteridinones as kinase inhibitors
WO2001038315A1 (en) 1999-11-22 2001-05-31 Warner-Lambert Company Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
EA200200643A1 (ru) * 2000-01-25 2002-12-26 Уорнер-Ламберт Компани ПИРИДО[2,3-d]ПИРИМИДИН-2,7-ДИАМИНОВЫЕ ИНГИБИТОРЫ КИНАЗ
KR20020070520A (ko) * 2000-01-27 2002-09-09 워너-램버트 캄파니 신경퇴행성 질병의 치료를 위한 피리도피리미디논 유도체
GB0004886D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004887D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004888D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
WO2001079198A1 (en) 2000-04-18 2001-10-25 Agouron Pharmaceuticals, Inc. Pyrazoles for inhibiting protein kinase
AU2001291013A1 (en) 2000-09-15 2002-03-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
HUP0400908A3 (en) 2000-12-21 2010-03-29 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors, their use and pharmaceutical compositions containing them
MXPA03010810A (es) 2001-05-29 2004-03-22 Schering Ag Pirimidinas inhibidoras de cdk, su obtencion y su uso como medicamentos.
US7288547B2 (en) 2002-03-11 2007-10-30 Schering Ag CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
CN1717396A (zh) 2002-11-28 2006-01-04 舍林股份公司 Chk－、Pdk－和Akt－抑制嘧啶,其制备及作为药物的用途
CA2515095A1 (en) 2003-02-10 2004-08-19 Pfizer Inc. Regimen of administration for nelfinavir
KR101173696B1 (ko) 2003-02-10 2012-08-13 바이엘 파마 악티엔게젤샤프트 플루오로퀴놀론의 국소 적용에 의한 호흡 기관의 세균성질환의 치료
DE10349423A1 (de) 2003-10-16 2005-06-16 Schering Ag Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel

Also Published As

Publication number Publication date
US20060229330A1 (en) 2006-10-12
NO20053410L (no) 2005-09-08
PL382309A1 (pl) 2007-08-20
US7615634B2 (en) 2009-11-10
US7157455B2 (en) 2007-01-02
EP1628619A2 (en) 2006-03-01
CL2004000226A1 (es) 2005-01-14
AR043693A1 (es) 2005-08-10
MY137555A (en) 2009-02-27
ECSP055958A (es) 2006-01-16
MA27716A1 (fr) 2006-01-02
RS20050610A (en) 2007-12-31
US20040162303A1 (en) 2004-08-19
WO2004069139A2 (en) 2004-08-19
MXPA05008333A (es) 2005-09-30
HRP20050689A2 (en) 2006-08-31
KR100717099B1 (ko) 2007-05-10
AU2004210408A1 (en) 2004-08-19
CA2512915A1 (en) 2004-08-19
JP2006523183A (ja) 2006-10-12
TWI293881B (en) 2008-03-01
KR20050099544A (ko) 2005-10-13
TNSN05188A1 (en) 2007-06-11
WO2004069139A3 (en) 2007-04-26
EA009412B1 (ru) 2007-12-28
TW200423940A (en) 2004-11-16
IL169626A0 (en) 2007-07-04
BRPI0407381A (pt) 2006-02-07

Similar Documents

Publication Publication Date Title
HK1087700A1 (en) Triazolopyridazines as protein kinases inhibitors
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
TNSN05188A1 (en) 4-aminopyrimidine-5-one
MY156407A (en) 5-phenylthiazole derivatives and use as p13 kinase inhibitors
PL1608647T3 (pl) Pochodne 5-fenylotiazolu i ich zastosowanie jako inhibitorów kinazy PI3
PL406680A1 (pl) Inhibitory kinaz tyrozynowych
HRP20070020T3 (en) 1-(2h-pyrazol-3-yl)-3- 4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl -urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
EA025871B9 (ru) Ингибиторы mek и способы их применения
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
GB0112348D0 (en) Compounds
NO20070681L (no) 2, 4, 6-Trisubstituterte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse i behandling av kreft
ATE499372T1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
WO2007012972A3 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
WO2006016067A3 (fr) Derives de pyrido-pyrimidine, leur preparation, leur application dans le traitement du cancer
CA2461622A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
ATE546452T1 (de) Pyrazolopyrrolderivate als proteinkinaseinhibitoren
ATE279410T1 (de) 3-aminopyrazole als inhibitoren von cyclinabhängigen kinasen
WO2004072029A3 (en) Pyrazolopyridazines useful as inhibitors of protein kinases
WO2002059109A3 (en) Naphthostyril derivatives and their use as inhibitors of cyclin- dependent kinases
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
WO2003080624A3 (en) Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
HK1082727A1 (en) 2" oxo-voruscharin and derivatives thereof

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU